Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/82058
DC Field | Value | Language |
---|---|---|
dc.contributor | Department of Applied Biology and Chemical Technology | - |
dc.creator | Lee, MY | en_US |
dc.creator | Han, Y | en_US |
dc.creator | Choi, CLZhang, Z | en_US |
dc.creator | Cui, W | en_US |
dc.date.accessioned | 2020-05-05T05:58:29Z | - |
dc.date.available | 2020-05-05T05:58:29Z | - |
dc.identifier.uri | http://hdl.handle.net/10397/82058 | - |
dc.language.iso | en | en_US |
dc.rights | Assignee: University of Macau | en_US |
dc.rights | Assignee: The Hong Kong Polytechnic University | en_US |
dc.title | Uses of indole-ketones or indolidones as neuro-protective drugs | en_US |
dc.type | Patent | en_US |
dc.description.otherinformation | US9486440; US9486440 B2; US9486440B2; US9,486,440; US9,486440 B2; 9486440; 15/836,54014/354,137 | en_US |
dcterms.abstract | The present invention provides a method of using indole-ketone or indolidone such as SU4312, SU5416, SU11248 (Sunitinib), or indirubin-3-oxime to treat a neurodegenerative disease or disorder such as Parkinson's disease which is associated with excessive neuronal Nitric Oxide Synthase (nNOS) activity. | - |
dcterms.bibliographicCitation | US Patent US9,486440 B2. Washington, DC: US Patent and Trademark Office, 2016. | en_US |
dcterms.issued | 2016-11-08 | - |
dc.description.country | US | - |
dc.description.validate | 202006 bcrc | - |
dc.description.oa | Version of Record | en_US |
Appears in Collections: | Patent |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
us9486440b2.pdf | 4.98 MB | Adobe PDF | View/Open |
Page views
11
Citations as of Jun 19, 2022
Downloads
5
Citations as of Jun 19, 2022

Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.